"Glioblastoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Descriptor ID |
D005909
|
| MeSH Number(s) |
C04.557.465.625.600.380.080.335 C04.557.470.670.380.080.335 C04.557.580.625.600.380.080.335
|
| Concept/Terms |
Glioblastoma- Glioblastoma
- Glioblastomas
- Astrocytoma, Grade IV
- Astrocytomas, Grade IV
- Grade IV Astrocytoma
- Grade IV Astrocytomas
Giant Cell Glioblastoma- Giant Cell Glioblastoma
- Giant Cell Glioblastomas
- Glioblastoma, Giant Cell
- Glioblastomas, Giant Cell
|
Below are MeSH descriptors whose meaning is more general than "Glioblastoma".
Below are MeSH descriptors whose meaning is more specific than "Glioblastoma".
This graph shows the total number of publications written about "Glioblastoma" by people in this website by year, and whether "Glioblastoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1997 | 4 | 0 | 4 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 1 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 5 | 0 | 5 |
| 2005 | 0 | 1 | 1 |
| 2006 | 3 | 2 | 5 |
| 2007 | 3 | 3 | 6 |
| 2008 | 1 | 0 | 1 |
| 2009 | 4 | 3 | 7 |
| 2010 | 15 | 1 | 16 |
| 2011 | 11 | 0 | 11 |
| 2012 | 9 | 0 | 9 |
| 2013 | 9 | 4 | 13 |
| 2014 | 6 | 4 | 10 |
| 2015 | 12 | 1 | 13 |
| 2016 | 5 | 0 | 5 |
| 2017 | 11 | 0 | 11 |
| 2018 | 8 | 2 | 10 |
| 2019 | 9 | 0 | 9 |
| 2020 | 5 | 0 | 5 |
| 2021 | 9 | 0 | 9 |
| 2022 | 5 | 0 | 5 |
| 2023 | 5 | 0 | 5 |
| 2024 | 8 | 0 | 8 |
| 2025 | 14 | 1 | 15 |
| 2026 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioblastoma" by people in Profiles.
-
Galanin impairs tumor immunity in glioblastoma by promoting infiltration and ferroptosis resistance of myeloid-derived suppressor cells. Nat Cancer. 2026 Sep; 7(9):1387-1405.
-
Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205. Clin Cancer Res. 2026 Aug 14; 32(16):3476-3492.
-
Tumor-targeted interferon-a gene therapy for glioblastoma: a phase 1 trial. Nat Med. 2026 Jun; 32(6):2216-2226.
-
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data. J Clin Oncol. 2026 Jul 20; 44(21):2048-2058.
-
Hypoxia Increases Connexin46 and Connexin43 Levels in KNS-42 Glioblastoma Cells. Int J Mol Sci. 2026 Mar 21; 27(6).
-
Symbiotic exclusivity between CLOCK and TFPI2 drives stemness and immunosuppression in glioblastoma models. J Clin Invest. 2026 May 15; 136(10).
-
Microglial fructose metabolism is essential for glioblastoma growth. Proc Natl Acad Sci U S A. 2026 Mar 24; 123(12):e2521256123.
-
Altered perivascular diffusivity in glioblastoma: integrating DTI-ALPS index with radio-pathomic and histopathologic correlates. J Neurooncol. 2026 Feb 21; 177(1).
-
LRRC8A-containing anion channels promote glioblastoma proliferation via a WNK1/mTORC2-dependent mechanism. J Physiol. 2026 Mar; 604(5):1995-2026.
-
Bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodeling in immune-competent preclinical models. J Immunother Cancer. 2025 Oct 28; 13(10).